SIGA Technologies, Inc. (NASDAQ:SIGA – Get Rating) hit a new 52-week high on Friday . The company traded as high as $23.00 and last traded at $22.26, with a volume of 250343 shares. The stock had previously closed at $19.47.
Analyst Upgrades and Downgrades
Separately, TheStreet downgraded shares of SIGA Technologies from a "b" rating to a "c+" rating in a research report on Monday, May 23rd.
Get SIGA Technologies alerts:SIGA Technologies Trading Up 19.7 %
The stock's fifty day moving average is $13.56 and its two-hundred day moving average is $9.35. The firm has a market cap of $1.69 billion, a P/E ratio of 24.27 and a beta of 0.63.
SIGA Technologies (NASDAQ:SIGA – Get Rating) last announced its quarterly earnings results on Thursday, May 5th. The company reported ($0.01) earnings per share for the quarter. The firm had revenue of $10.54 million for the quarter. SIGA Technologies had a net margin of 48.67% and a return on equity of 47.99%. On average, analysts forecast that SIGA Technologies, Inc. will post 0.66 EPS for the current year.Institutional Trading of SIGA Technologies
A number of large investors have recently made changes to their positions in the stock. Allspring Global Investments Holdings LLC purchased a new stake in SIGA Technologies in the 4th quarter worth $3,517,000. Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of SIGA Technologies during the second quarter worth approximately $3,346,000. Renaissance Technologies LLC increased its holdings in SIGA Technologies by 44.9% during the fourth quarter. Renaissance Technologies LLC now owns 893,504 shares of the company's stock valued at $6,719,000 after buying an additional 276,814 shares during the period. Kempen Capital Management N.V. grew its holdings in SIGA Technologies by 19.5% in the first quarter. Kempen Capital Management N.V. now owns 1,376,982 shares of the company's stock worth $9,763,000 after purchasing an additional 224,423 shares during the last quarter. Finally, Hillsdale Investment Management Inc. purchased a new position in SIGA Technologies in the first quarter worth $1,133,000. 34.52% of the stock is currently owned by institutional investors.
SIGA Technologies Company Profile
(Get Rating)
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats.
See Also
- Get a free copy of the StockNews.com research report on SIGA Technologies (SIGA)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc's Revenues Are Up, Is It Time to Buy?
- Why Apple Could Be At All-Time Highs By Year End
- Beyond Meat Is Not Beyond Hope, And It's Cheap
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
